This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Apollo Intelligent Connectivity (Beijing) Technology Co., Ltd., Beijing Institute for Cancer Research, Beijing Xiaomi Mobile Software Co., Ltd.. Active years: 2007-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2007-2025
Title: The Innovative Journey of Lin Meng
Introduction
Lin Meng, an accomplished inventor based in Beijing, China, has made significant contributions to the fields of virtual reality and medical research. With two patents to his name, his work showcases a blend of technological innovation and a commitment to advancing healthcare solutions.
Latest Patents
Lin Meng's latest patents include a pioneering "Method and Apparatus for Testing Virtual Reality Head Display Device." This invention details a sophisticated method for analyzing pairs of images derived from head display devices to ascertain their ability to produce stereoscopic images perceptible by human eyes. His second patent, "Antagonist Peptides to VEGF Receptor Flt-1," focuses on a polypeptide designed for treating angiogenic diseases, such as solid tumors, and offers potential applications in gene therapy through a specific polynucleotide.
Career Highlights
Throughout his career, Lin Meng has worked with esteemed organizations, including Xiaomi Mobile Software Co., Ltd. and the Beijing Institute for Cancer Research. His efforts have not only enriched his own career but have also driven innovation within these companies.
Collaborations
Lin has collaborated with notable colleagues such as Boxuan Wang and Lu Han, indicating his active engagement in the research community and fostering partnerships that enhance the development of groundbreaking technologies.
Conclusion
Lin Meng's contributions to the fields of virtual reality and medical science underscore the importance of innovation in addressing contemporary challenges. His patents reflect a dedication to enhancing user-experience technology as well as improving health outcomes, paving the way for future advancements in these crucial areas.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile